{"id":15536,"date":"2021-11-08T00:00:00","date_gmt":"2021-11-08T00:00:00","guid":{"rendered":"https:\/\/makingpharmaindustry.it\/non-categorizzato\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/"},"modified":"2023-08-28T14:54:30","modified_gmt":"2023-08-28T14:54:30","slug":"cphi-worldwide-expansion-of-api-pipeline-for-olon-group","status":"publish","type":"post","link":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/","title":{"rendered":"CPhI Worldwide, significant expansion of APIs pipeline for Olon Group"},"content":{"rendered":"<p style=\"text-align: right;\"><span class=\"td_text_highlight_marker_red td_text_highlight_marker\">COMPANY NEWS<\/span><\/p>\r\n\r\n<p>As in Milan (Italy) takes place <strong><a href=\"https:\/\/www.cphi.com\/europe\/en\/home.html\" target=\"_blank\" rel=\"noreferrer noopener\">CPhI Worldwide 2021<\/a><\/strong>, the largest international event dedicated to the pharmaceutical and chemical-pharmaceutical industry, the <strong><a href=\"https:\/\/makingconnect.it\/en\/company\/olon\/\">Olon Group<\/a> is pleased to announce a significant expansion of its pipeline of active pharmaceutical ingredients<\/strong>, a result of its R&amp;D investment strategy.<\/p>\r\n\r\n\r\n\r\n<p>The event is representative of the pharmaceutical industry\u2019s entire supply chain, and the producers of active substances and outsourced manufacturing \u2014 for which Olon is one of the major Italian representatives \u2014 are the &#8220;backbone&#8221;.<\/p>\r\n\r\n\r\n\r\n<p>With a global network of production sites, the Italian Group is a leader in the production of generic and CDMO APIs, for chemical as well as biological synthesis. Relying on one of the sector\u2019s longest track records and a significant investment in R&amp;D, at the CPhI, <strong>Olon will present a pipeline enriched with 9 new active substances for the generic market.<\/strong> The expansion of the pipeline \u2014 a result of continuous investment in internal R&amp;D \u2014 represents diversification in terms of therapeutic areas and molecule types, with the introduction, for example, of <strong>new APIs in multiple sclerosis and the treatment of anaemia, as well as in terms of implementing new synthesis routes. Olon apply to development and industrial manufacturing some of the most advanced technologies, among the foremost there are biocatalysis, fluorination, cryogenic reaction and flow chemistry.<\/strong><\/p>\r\n\r\n\r\n\r\n<blockquote class=\"wp-block-quote is-layout-flow wp-block-quote-is-layout-flow\"><p>Thanks to our experience in the generics market, we are known for our ability to adapt to specific quality, physical and chemical needs, as well as IP strategies that allow a prompt access to quality and affordable medicine generics as quickly as possible<\/p><p>Paolo Tubertini, CEO at Olon Group<\/p><\/blockquote>\r\n\r\n\r\n\r\n<p>Olon has diversified and backed investments across several lines and multiple facilities to be able to <strong>manage various high-containment molecules at different scales and guarantee flexibility on a significant scale.<\/strong><\/p>\r\n\r\n\r\n\r\n<p>Olon\u2019s pipeline of generic APIs is reinforced in the oncology area, where the Group has solid expertise as one of the sector\u2019s top companies producing high-activity active substances, with the introduction of numerous anti-tumour APIs, particularly those with selective high activity.<\/p>\r\n\r\n\r\n\r\n<h2 class=\"wp-block-heading\">Related articles<\/h2>\r\n\r\n\r\n\r\n<p><a href=\"https:\/\/makingconnect.it\/en\/the-ima-group-at-cphi-milan-2021\/\">The IMA Group at CPhI Milan 2021<\/a><\/p>\r\n\r\n\r\n\r\n<p><a href=\"https:\/\/makingconnect.it\/en\/olon-ricerca-bioscience\/\">Olon Group announces the next strategic milestone of Olon Ricerca Bioscience<\/a><\/p>\r\n","protected":false},"excerpt":{"rendered":"<p>COMPANY NEWS As in Milan (Italy) takes place CPhI Worldwide 2021, the largest international event dedicated to the pharmaceutical and chemical-pharmaceutical industry, the Olon Group is pleased to announce a significant expansion of its pipeline of active pharmaceutical ingredients, a result of its R&amp;D investment strategy. The event is representative of the pharmaceutical industry\u2019s entire [&hellip;]<\/p>\n","protected":false},"author":32,"featured_media":15670,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[812],"tags":[],"class_list":{"0":"post-15536","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-api-excipients"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>CPhI Worldwide, significant expansion of APIs pipeline for Olon Group - MakingPharmaIndustry<\/title>\n<meta name=\"description\" content=\"As in Milan takes place CPhI Worldwide 2021, the Olon Group announces an expansion of its pipeline of active pharmaceutical ingredients\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CPhI Worldwide, significant expansion of APIs pipeline for Olon Group - MakingPharmaIndustry\" \/>\n<meta property=\"og:description\" content=\"As in Milan takes place CPhI Worldwide 2021, the Olon Group announces an expansion of its pipeline of active pharmaceutical ingredients\" \/>\n<meta property=\"og:url\" content=\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/\" \/>\n<meta property=\"og:site_name\" content=\"MakingPharmaIndustry\" \/>\n<meta property=\"article:published_time\" content=\"2021-11-08T00:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-08-28T14:54:30+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2023\/07\/PCS4883-scaled-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1707\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Valentina Parrella\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Valentina Parrella\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/\"},\"author\":{\"name\":\"Valentina Parrella\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b\"},\"headline\":\"CPhI Worldwide, significant expansion of APIs pipeline for Olon Group\",\"datePublished\":\"2021-11-08T00:00:00+00:00\",\"dateModified\":\"2023-08-28T14:54:30+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/\"},\"wordCount\":371,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2023\/07\/PCS4883-scaled-1.jpg\",\"articleSection\":[\"API &amp; Excipients\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/\",\"name\":\"CPhI Worldwide, significant expansion of APIs pipeline for Olon Group - MakingPharmaIndustry\",\"isPartOf\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2023\/07\/PCS4883-scaled-1.jpg\",\"datePublished\":\"2021-11-08T00:00:00+00:00\",\"dateModified\":\"2023-08-28T14:54:30+00:00\",\"author\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b\"},\"description\":\"As in Milan takes place CPhI Worldwide 2021, the Olon Group announces an expansion of its pipeline of active pharmaceutical ingredients\",\"breadcrumb\":{\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/#primaryimage\",\"url\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2023\/07\/PCS4883-scaled-1.jpg\",\"contentUrl\":\"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2023\/07\/PCS4883-scaled-1.jpg\",\"width\":2560,\"height\":1707,\"caption\":\"CPhI Worldwide, significant expansion of APIs pipeline for Olon Group\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/makingpharmaindustry.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CPhI Worldwide, significant expansion of APIs pipeline for Olon Group\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#website\",\"url\":\"https:\/\/makingpharmaindustry.it\/en\/\",\"name\":\"MakingPharmaIndustry\",\"description\":\"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b\",\"name\":\"Valentina Parrella\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g\",\"caption\":\"Valentina Parrella\"},\"url\":\"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CPhI Worldwide, significant expansion of APIs pipeline for Olon Group - MakingPharmaIndustry","description":"As in Milan takes place CPhI Worldwide 2021, the Olon Group announces an expansion of its pipeline of active pharmaceutical ingredients","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/","og_locale":"en_US","og_type":"article","og_title":"CPhI Worldwide, significant expansion of APIs pipeline for Olon Group - MakingPharmaIndustry","og_description":"As in Milan takes place CPhI Worldwide 2021, the Olon Group announces an expansion of its pipeline of active pharmaceutical ingredients","og_url":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/","og_site_name":"MakingPharmaIndustry","article_published_time":"2021-11-08T00:00:00+00:00","article_modified_time":"2023-08-28T14:54:30+00:00","og_image":[{"width":2560,"height":1707,"url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2023\/07\/PCS4883-scaled-1.jpg","type":"image\/jpeg"}],"author":"Valentina Parrella","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Valentina Parrella","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/#article","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/"},"author":{"name":"Valentina Parrella","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b"},"headline":"CPhI Worldwide, significant expansion of APIs pipeline for Olon Group","datePublished":"2021-11-08T00:00:00+00:00","dateModified":"2023-08-28T14:54:30+00:00","mainEntityOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/"},"wordCount":371,"commentCount":0,"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2023\/07\/PCS4883-scaled-1.jpg","articleSection":["API &amp; Excipients"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/","url":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/","name":"CPhI Worldwide, significant expansion of APIs pipeline for Olon Group - MakingPharmaIndustry","isPartOf":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/#primaryimage"},"image":{"@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/#primaryimage"},"thumbnailUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2023\/07\/PCS4883-scaled-1.jpg","datePublished":"2021-11-08T00:00:00+00:00","dateModified":"2023-08-28T14:54:30+00:00","author":{"@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b"},"description":"As in Milan takes place CPhI Worldwide 2021, the Olon Group announces an expansion of its pipeline of active pharmaceutical ingredients","breadcrumb":{"@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/#primaryimage","url":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2023\/07\/PCS4883-scaled-1.jpg","contentUrl":"https:\/\/makingpharmaindustry.it\/wp-content\/uploads\/2023\/07\/PCS4883-scaled-1.jpg","width":2560,"height":1707,"caption":"CPhI Worldwide, significant expansion of APIs pipeline for Olon Group"},{"@type":"BreadcrumbList","@id":"https:\/\/makingpharmaindustry.it\/en\/manufacturing\/api-excipients\/cphi-worldwide-expansion-of-api-pipeline-for-olon-group\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/makingpharmaindustry.it\/en\/"},{"@type":"ListItem","position":2,"name":"CPhI Worldwide, significant expansion of APIs pipeline for Olon Group"}]},{"@type":"WebSite","@id":"https:\/\/makingpharmaindustry.it\/en\/#website","url":"https:\/\/makingpharmaindustry.it\/en\/","name":"MakingPharmaIndustry","description":"Luogo di incontro\u00a0per approfondire e discutere le pi\u00f9 importanti tematiche del mondo Pharma, dalla ricerca e sviluppo al manufacturing, dal mercato al business","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/makingpharmaindustry.it\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/makingpharmaindustry.it\/en\/#\/schema\/person\/a17e8d1b62d20f6ded5c1564729ba42b","name":"Valentina Parrella","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/9489e527cae2d980412b4296f66093487551a8e1010c544334080d6b66e72eeb?s=96&d=mm&r=g","caption":"Valentina Parrella"},"url":"https:\/\/makingpharmaindustry.it\/en\/author\/valentina-parrella\/"}]}},"_links":{"self":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/15536","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/users\/32"}],"replies":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/comments?post=15536"}],"version-history":[{"count":2,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/15536\/revisions"}],"predecessor-version":[{"id":16294,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/posts\/15536\/revisions\/16294"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media\/15670"}],"wp:attachment":[{"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/media?parent=15536"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/categories?post=15536"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/makingpharmaindustry.it\/en\/wp-json\/wp\/v2\/tags?post=15536"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}